Capital Medica Ventures
17
1M
11
2.83
1
0.35
- Areas of investment
Summary
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Capital Medica Ventures, startups are often financed by Senshu Ikeda Capital, Miyako Capital, Kenshin Fujiwara. The meaningful sponsors for the fund in investment in the same round are PALTEK, Ohara Pharmaceutical, Miyako Capital. In the next rounds fund is usually obtained by Mitsubishi Research Institute, Aflac Corporate Ventures.
The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2018. Deals in the range of 1 - 5 millions dollars are the general things for fund.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Life Science, Artificial Intelligence. Among the most popular portfolio startups of the fund, we may highlight Hacarus.
Investments analytics
Analytics
- Total investments
- 17
- Lead investments
- 1
- Rounds per year
- 2.83
- Follow on index
- 0.35
- Investments by industry
- Beauty (7)
- Task Management (6)
- SaaS (6)
- Health Care (5)
- Medical (4) Show 18 more
- Investments by region
-
- Japan (17)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 5
- Group Appearance index
- 0.82
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| BrainCare Japan | 14 Jun 2017 | E-Learning, Health Care, Education | Seed | 91K | Chiyoda, Japan |
| Epigno | 20 Apr 2020 | Software, Information Services, Health Care, Hospital | Seed | 910K | Minato, Japan |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.